* VERONA PHARMA PLC – ‍ANTICIPATES REPORTING TOP-LINE DATA
FROM
ITS PHASE 2B TRIAL EARLY IN Q2 OF 2018 FOR NEBULIZED RPL554​

Read More At Article Source | Article Attribution